Alto Neuroscience Cash Flow Statement 2021-2024 | ANRO

Fifteen years of historical annual cash flow statements for Alto Neuroscience (ANRO).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202320222021
$-36.31$-27.71$-9.19
$0.37$0.34$0.15
$3.18$2.40$0.35
$3.56$2.74$0.50
$0$0$-1.29
$0$0$0
$-0.63$1.01$0.46
$0.29$1.10$-0.38
$-0.70$4.58$-0.57
$-33.45$-20.39$-9.26
$-0.47$-0.73$-0.68
$0$0$0
$0$0$0
$0$0$0
$0$0$0
$0$0$0
$0$0$0
$-0.47$-0.73$-0.68
$0$9.83$0
$0$0$0
$0$9.83$0
$0.18$0.04$0.01
$70.18$34.31$31.89
$0$0$0
$-2.05$-0.34$-0.21
$68.13$43.79$31.69
$34.20$22.64$21.70
$2.89$1.76$0.23
$0$0$0